FDA Adverse Event Malfunction Summary report: N

MYNX CADENCE VASCULAR CLOSURE DEVICE 5F

MDR report key: 2840219 · Received June 28, 2012

Report

Report Number
3004939290-2012-00172
Event Type
Malfunction
Date Received
June 28, 2012
Report Date
May 30, 2012
Manufacturer
ACCESSCLOSURE, INC.
Product Code
MGB
PMA / PMN Number
P040044
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS RECEIVED WITH THE SHUTTLE CARTRIDGE ENGAGED TO THE HANDLE AND THE INTRODUCER SHEATH WAS PULLED BACK AGAINST THE HANDLE. THE SEALANT WAS FLARED OVER THE BALLOON PROXIMAL BOND. THE BALLOON HAD A SEVERELY INVERTED TIP. THE ADVANCER TUBE WAS COMPRESSING AGAINST THE SEALANT. THE PROXIMAL TAMP LOCK OF THE RETURNED DEVICE WAS DISLODGED RESULTING IN OVER SHUTTLING. BASED ON THE PROVIDED INFORMATION AND THE INVESTIGATION PERFORMED, THE CAUSE FOR THE TAMP LOCK DETACHMENT IS DUE TO A BOND FAILURE AT THE POLYIMIDE SHAFT. THE REVIEW OF THE LHR (LOT F1208801) INDICATED THAT THE MYNX LOT MET ALL ESTABLISHED PERFORMANCE CRITERIA PRIOR TO SHIPMENT.

Description of Event or Problem · 1

IT WAS REPORTED BY THE ACI VASCULAR CLOSURE SPECIALIST THAT A PT UNDERWENT A DIAGNOSTIC CORONARY PROCEDURE SOMETIME IN THE WEEK OF (B)(6) 2012. ACCESS WAS OBTAINED AT THE COMMON FEMORAL ARTERY VIA A 5F SHEATH (MODEL UNKNOWN). A PRE-PROCEDURE FEMORAL ANGIOGRAM SHOWED THE VESSEL SIZE TO BE APPROXIMATELY 6 MM. FOLLOWING THE PROCEDURE, THE PHYSICIAN WHO IS A TRAINED USER, SELECTED THE MYNX CADENCE VASCULAR CLOSURE DEVICE 5F TO CLOSE THE ACCESS SITE. IT WAS REPORTED THAT THE "SEALANT FAILED TO DEPLOY PROPERLY." THE DEVICE WAS REMOVED AND THE PT WAS CONVERTED TO APPROXIMATELY 20 MINUTES OF MANUAL COMPRESSION. HEMOSTASIS WAS ACHIEVED. NO FURTHER INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MYNX CADENCE VASCULAR CLOSURE DEVICE 5F MGB, PRODUCT CODE: MGB MGB ACCESSCLOSURE, INC. MX5001 F1208801

Patients

Seq Age Sex Outcome Treatment
1